Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HK.34.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.124.1.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.203ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.8.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GY.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.7.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.254ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.36.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.122.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.79 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.209ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.236ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XQENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.59ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.395ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.120.2.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.416.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.532ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.408ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XHENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.423ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.550ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.261ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.3.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EP.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.15.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCBENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.15.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.8.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XSENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.74ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.6.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.238ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.68ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used